DE60238528D1 - Ene pharmazeutika und ihre verwendung als kontrazeptiva - Google Patents

Ene pharmazeutika und ihre verwendung als kontrazeptiva

Info

Publication number
DE60238528D1
DE60238528D1 DE60238528T DE60238528T DE60238528D1 DE 60238528 D1 DE60238528 D1 DE 60238528D1 DE 60238528 T DE60238528 T DE 60238528T DE 60238528 T DE60238528 T DE 60238528T DE 60238528 D1 DE60238528 D1 DE 60238528D1
Authority
DE
Germany
Prior art keywords
pharmaceutical
animal
protein
homogenate
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60238528T
Other languages
English (en)
Inventor
Dwayne Kirk
Hugh Mason
Amanda Walmsley
Charles Arntzen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
THOMPSON BOYCE PLANT RES
Original Assignee
THOMPSON BOYCE PLANT RES
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by THOMPSON BOYCE PLANT RES filed Critical THOMPSON BOYCE PLANT RES
Application granted granted Critical
Publication of DE60238528D1 publication Critical patent/DE60238528D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8257—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon
    • C12N15/8258—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon for the production of oral vaccines (antigens) or immunoglobulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/36—Antigestagens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245—Escherichia (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8257—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Reproductive Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gynecology & Obstetrics (AREA)
  • Toxicology (AREA)
  • Diabetes (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
DE60238528T 2001-04-13 2002-04-12 Ene pharmazeutika und ihre verwendung als kontrazeptiva Expired - Lifetime DE60238528D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US28388401P 2001-04-13 2001-04-13
PCT/US2002/011693 WO2002083072A2 (en) 2001-04-13 2002-04-12 Methods and compositions for stable transgenic plant pharmaceuticals and their use as contraceptives

Publications (1)

Publication Number Publication Date
DE60238528D1 true DE60238528D1 (de) 2011-01-20

Family

ID=23087984

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60238528T Expired - Lifetime DE60238528D1 (de) 2001-04-13 2002-04-12 Ene pharmazeutika und ihre verwendung als kontrazeptiva

Country Status (12)

Country Link
EP (1) EP1389997B1 (de)
JP (1) JP4500493B2 (de)
KR (1) KR20030096319A (de)
CN (1) CN1311077C (de)
AT (1) ATE491034T1 (de)
AU (1) AU2002256205B2 (de)
BR (1) BR0208880A (de)
CA (1) CA2441699A1 (de)
DE (1) DE60238528D1 (de)
ES (1) ES2357321T3 (de)
MX (1) MXPA03009196A (de)
WO (1) WO2002083072A2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1546309A4 (de) * 2002-09-19 2007-05-23 Res Dev Foundation In pflanzen exprimierte tierische immunkontrazeptiva
US20050009188A1 (en) * 2002-09-19 2005-01-13 Kitto G. Barrie Animal immunocontraceptives expressed in plants and uses thereof
US7317142B2 (en) 2002-12-13 2008-01-08 Prodi Gene, Inc. Immunization of fish with plant-expressed recombinant proteins
AU2004222243A1 (en) * 2003-03-18 2004-09-30 Rutgers, The State University Improved plant transformation
BRPI0410340A (pt) * 2003-05-05 2006-05-30 Dow Agrosciences Llc vetores e células para preparar composições imunoprotetoras derivadas de plantas transgênicas
CN1981835B (zh) * 2005-12-15 2010-12-15 孔庆建 一种中药避孕液及其制备工艺
DE102016204033A1 (de) * 2016-03-11 2017-09-14 Universität Rostock Maßnahmen und Methoden zur Schadtierbekämpfung
CN107158373B (zh) * 2017-05-25 2021-06-11 新疆大学 阿魏菇多糖在制备犬透明带3dna疫苗佐剂中的应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3650689T2 (de) * 1985-04-18 1999-04-08 Biotech Australia Pty Ltd Rekombinantes inhibin
CA1339307C (en) * 1988-09-06 1997-08-19 Roy Curtiss, Iii Oral immunization by transgenic plants
US5484719A (en) * 1991-08-26 1996-01-16 Edible Vaccines, Inc. Vaccines produced and administered through edible plants
EP0787496B1 (de) * 1996-01-31 2003-05-28 ABOCA S.p.A. Verfahren zur Gewinnung von Multifraktions-Trockenextrakten aus Pflanzen
FR2760366B1 (fr) * 1997-03-04 2000-08-11 Harbex Limited Hydrolysat d'extrait lyophilise de potiron et son procede de fabrication
CN1309663A (zh) * 1998-06-17 2001-08-22 贝斯以色列护理医疗中心 抗血管生成蛋白及其应用
CN1330718A (zh) * 1998-10-07 2002-01-09 辛根塔参与股份公司 植物中的治疗活性蛋白质

Also Published As

Publication number Publication date
MXPA03009196A (es) 2004-02-17
CA2441699A1 (en) 2002-10-24
ES2357321T3 (es) 2011-04-25
JP4500493B2 (ja) 2010-07-14
CN1311077C (zh) 2007-04-18
JP2004537287A (ja) 2004-12-16
BR0208880A (pt) 2004-12-07
ATE491034T1 (de) 2010-12-15
WO2002083072A3 (en) 2003-04-17
CN1639331A (zh) 2005-07-13
WO2002083072A2 (en) 2002-10-24
EP1389997A4 (de) 2004-08-11
EP1389997A2 (de) 2004-02-25
KR20030096319A (ko) 2003-12-24
AU2002256205B2 (en) 2007-08-16
EP1389997B1 (de) 2010-12-08

Similar Documents

Publication Publication Date Title
NO20045521L (no) Diarylureaderivater anvendelige for behandling av proteinkinaseavhengige sykdommer
PT1436381E (pt) Celulas estaminais desdiferenciadas e programaveis de origem monocitaria e sua producao e utilizacao
NO20016159L (no) Serinproteinaser fra fisk og deres farmasöytiske og kosmetiske anvendelse
DE60238528D1 (de) Ene pharmazeutika und ihre verwendung als kontrazeptiva
ATE330608T1 (de) Die verwendung von n-phenyl-2-pyrimidine-amine derivaten zur behandlung von entzündlichen erkrankungen
DE60216281D1 (de) Die verwendung von tyrosinkinasehemmer zur behandlung von allergischen erkrankungen
DE60227701D1 (de) Die verwendung von c-kithemmern zur förderung des haarwuchses
ATE345354T1 (de) Methode zur identifizierung von helicobacter antigenen
TR200100637T2 (tr) Yeni doğal ürün türevleri
DE60322724D1 (de) Gentechnische manipulation kondensierter tannine
DK1290160T3 (da) Humane Pellino-polypeptider
HN1998000141A (es) Composicion farmaceutica antimastitica a base de extractos de origen natural y procedimientom para fabricarla.
ATE374038T1 (de) Verwendung von bakteriellen pard kis/pard kid toxin-antitoxin system zur tötung von eukaryotischen zellen
WO2003012035A3 (en) Commercial use of arabidopsis for production of human and animal therapeutic and diagnostic proteins
ATE316379T1 (de) Oxyhuminsäure und ihre verwendung zur behandlung von verschiedenenen störungen
NO20005345L (no) Fruktbarhetsforbedrende preparat og anvendelse derav
PL440339A1 (pl) Frakcja białkowa otrzymana z płynu celomatycznego dżdżownicy Dendrobaena veneta do zastosowania w leczeniu raka szyjki macicy ludzkiej
NO20070661L (no) Anvendelsen av medisinske planter og ekstrakter derav for dyrs velvaere i veterinaer medisin og zooteknikk
DE69332412T2 (de) Stammzellen proliferationsfaktor
DK1196579T3 (da) Tryptaseinhibitor
ATE415419T1 (de) Inaktivierte zytokine zur immunisierung
UA36895A (uk) Спосіб трансплантації рогівки у тварин
AR015367A1 (es) Control de la induccion floral en plantas y usos para las mismas.
BR0313099A (pt) método para manter a eficácia pesticida de plantas transgênicas
BR0301511A (pt) Processo para isolamento de peptìdeos utilizando as endopeptidades ec 3.4.24.15 (ep24.15) e ec 3.4.24.16 (ep24.16)recombinantes, cataliticamente inativadas por mutação sìtio dirigida